Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NIH × Polyps × Clear all

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 66 Lung Neoplasms 32 Leukemia 31 Colonic Neoplasms 31 Carcinoma, Non-Small-Cell Lung 30 Rectal Neoplasms 27 Colorectal Neoplasms 27 Lymphoma 26 Prostatic Neoplasms 23 Multiple Myeloma 21 Ovarian Neoplasms 18 Lymphoma, Follicular 18 Lymphoma, Non-Hodgkin 17 Leukemia, Myeloid, Acute 17 Melanoma 15 Lymphoma, Large B-Cell, Diffuse 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Neoplasms, Plasma Cell 14 Lymphoma, Large-Cell, Immunoblastic 13 Burkitt Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Head and Neck Neoplasms 12 Carcinoma, Ovarian Epithelial 12 Urinary Bladder Neoplasms 11 Pancreatic Neoplasms 11 Leukemia, Myelomonocytic, Acute 11 Leukemia, Monocytic, Acute 11 Leukemia, Megakaryoblastic, Acute 11 Leukemia, Erythroblastic, Acute 11 Central Nervous System Neoplasms 11

Interventions

Diet, Fat-Restricted 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00339625 2020-05-15

Polyp Prevention Trial

National Institutes of Health Clinical Center (CC)

Phase 3 Completed

Adenoma, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡